Getitall, the CEO of Gooddrug LLC claimed that in the US, drug companies should receive a patent of 100 years for each drug they develop. this allows them a prolonged Illegal monopoly on the sale of that drug, provide better incentives to innovate and help consumer pay stable prices. Jane, the FDA consultant strongly disagree with that statement. Give reasons related to consumers, patients, and the market to support Jane's claim

Getitall, the CEO of Gooddrug LLC claimed that in the US, drug companies should receive a patent of 100 years for each drug they develop. this allows them a prolonged Illegal monopoly on the sale of that drug, provide better incentives to innovate and help consumer pay stable prices. Jane, the FDA consultant strongly disagree with that statement. Give reasons related to consumers, patients, and the market to support Jane's claim

EBK HEALTH ECONOMICS AND POLICY

7th Edition

ISBN:9781337668279

Author:Henderson

Publisher:Henderson

Chapter9: The Physicians’ Services Market

Section: Chapter Questions

Problem 5QAP

See similar textbooks

Similar questions

Question The Orphan Drug Act provides special patent protection and financial support from the state government for drugs designed to treat patients with diseases or conditions that effect 200,000 people or less. True False
Licensure requirements give physicians a monopoly privilege to practice medicine. As such, they have certain responsibilities and obligations. True False
3.4. EZjoint. After spending 10 years and $1.5 billion, you have finally gotten Food and Drug Administration (FDA) approval to sell your new patented wonder drug, which reduces the aches and pains associated with aging joints. You will market this drug under the brand name of EZjoint. Market research indicates that the demand elasticity for EZjoint is 21.25 (at all points on the demand curve). You estimate the marginal cost of manufacturing and selling one more dose of EZjoint is $1. (a) What is the profit-maximizing price per dose of EZjoint? (b) WouldyouexpecttheelasticityofdemandyoufaceforEZjointtoriseorfall when your patent expires? Suppose that, after patent expiry, a generic version of EZjoint was introduced in the market (under the chemical name clorophospartane). Reacting to entry, EZjoint decided to increase price. (c) Can this behavior be consistent with rational profit maximizing? (Cabral, 20170224)
1. Given the following table *Table attached* (a) Calculate the average cost-effectiveness ratio for drug A, B, C, D, E (b) Calculate the ICER between drug B and drug C, and between drug E and drug D. (c) Draw a cost-effectiveness frontier, where Y-axis represents effectiveness, X-axis represents a cost.
In generic drug pricing what is the impact competitors and additional factors have on the results of the generic drug pricing strategies?
Several Governments in CARICOM nations are reluctant to allow the provision oftelecommunication services by multiple providers. They prefer that a GovernmentAgency provides these services as they believe that consumers will be protected.However the revenue they gain should not be ignored as a possible motive. A recentstudy found that 8 countries out of the 15 in the CARICOM nations’ havetelecommunication services being provided by the a state company. For example, in St.Lucia, De Phone is the sole provider of telecoms. They offer discounts to senior citizensand students and also provide a lower price for individual who purchase multiple plans.Of note, the remaining CARICOM nations, including Trinidad and Tobago, have openedtheir markets to competition. These countries have seen increased advertising amongcompetitors to market their product.i. State what market structure exists in St. Lucia and illustrate how equilibrium priceand quantity determined in this industry. ii. Can excess…
Below is the abstract of a recentNational Bureau of Economic Research working paper entitled “Can governments do it better? Merger mania and hospital outcomes in the English NHS” by Martin Gaynor, Mauro Laudicella, and Carol Propper (2011). The literature on mergers between private hospitals suggests that such mergers often produce little benefit. Despite this, the UK government has pursued an active policy of hospital mergers. These mergers are initiated by a regulator, acting on behalf of the public, and justified on the grounds that merger will improve outcomes. We examine whether this promise is met. We exploit the fact that between 1997 and 2006 in England around half the short term general hospitals were involved in a merger, but that politics means that selection for a merger may be random with respect to future performance. We examine the impact of mergers on a large set of outcomes including financial performance, productivity, waiting times and clinical quality and find…
Imperfect competition and moral hazard. Some economists have argued that moral hazard and monopolistic health care markets are two socially inefficient problems that partially cancel each other out. Relative to the optimal level of health care Q∗, how much health care is provided in the presence of moral hazard? Assume perfectly competitive health care markets. Relative to the optimal level of health care Q∗, how much health care is provided in the presence of monopolistic health care markets? Assume no moral hazard. Write a one-sentence defense of the argument that moral hazard and imperfectly competitive health care markets could combine to provide a good level of health care provision Q.
do this ignore leacture information
The below table shows the total revenues and total cost of running a pharmacy.
Why are generic pharmaceuticals significantly cheaper than name brand ones?
The New York Times has stated that Mylan, the company that makes the now infamous Epipen, has become “the poster boy for out of control drug prices.” Why did this Pittsburgh-based company raise prices so much that Americans pay three times as much as Canadians for the same drug? Do you think patents are good for society?